Integrative Science

🇬🇧 English

True Integrative Medicine Does Not Compete With Medical Diagnosis — It Builds Upon It

When we look for triggers… where does our role in integrative care begin?

In autoimmune diseases, it is essential to distinguish between diagnosing and medically treating the disease itself and addressing associated factors and concerns that may influence the patient’s overall health and quality of life.

In our field, we do not begin by assuming that every case of fatigue or inflammation is caused by a “leaky gut,” nor do we conclude that grief or psychological stress caused an autoimmune disease simply because it preceded the onset of symptoms.

We wait for proper investigation and diagnosis by the appropriate medical specialist.

The first question is therefore not:

“What was the trigger?”

Instead, we ask:

What is the disease? Has the diagnosis been established? How active is it? Which organs are involved? Are there red flags or complications requiring medical management or referral?

Once this foundation is established, integrative supportive care can work alongside appropriate medical follow-up and prescribed treatment when indicated.

This is where we begin looking at the broader clinical picture, including:

Gastrointestinal health

Sleep & circadian health

Stress regulation

Physical activity and recovery

Neuro-immune-informed support

Medication–supplement interactions: “Natural” does not automatically mean “safe,” particularly when a patient is taking corticosteroids, immunosuppressants, biologics, or targeted therapies.

Comorbidities and cardiometabolic risk: including weight, blood pressure, glucose regulation, lipids, and bone health, depending on the disease and treatments being used.

And here lies a fundamental principle:

Support ≠ Replacement

Improving sleep, nutrition, gastrointestinal health, or stress management may provide meaningful support, but this does not automatically mean that the underlying autoimmunity has stopped.

If a patient requires a DMARD, immunosuppressive therapy, biologic, or targeted therapy to protect the joints, skin, kidneys, lungs, nervous system, blood vessels, or other organs, that treatment should not be replaced by supplements, dietary interventions, or an endless search for a “root cause.”

At the same time, this does not mean supportive care is unimportant.

Rather, we can think of these as two complementary pathways:

Medical diagnosis & disease control
→ Establish the diagnosis
→ Assess disease activity and organ involvement
→ Control abnormal inflammation and immune activity
→ Prevent organ damage and complications

Integrative supportive care
→ Assess associated and modifiable factors
→ Address documented deficiencies
→ Address gastrointestinal symptoms when present
→ Support sleep
→ Support stress regulation
→ Encourage appropriate movement
→ Support metabolic health
→ Review supplement safety and potential interactions
→ Support quality of life and adherence to the medical treatment plan

The goal is not to say:

“We found the trigger; therefore, we treated the autoimmune disease.”

Rather:

We first understand the disease, respect the diagnosis, pathophysiology, and necessary medical treatment, and then systematically identify associated and modifiable factors that can be supported within our professional scope.

For me, this is the meaning of clinical integrative care:

Investigate → Diagnose → Identify red flags → Understand the pathophysiology → Respect medical treatment → Then integrate individualized supportive care.

True Integrative Medicine does not compete with medical diagnosis — it builds upon it.




---

🇫🇷 Français

La véritable médecine intégrative ne concurrence pas le diagnostic médical — elle s’appuie sur celui-ci

Lorsque nous recherchons les facteurs déclencheurs… où commence notre rôle dans les soins intégratifs ?

Dans les maladies auto-immunes, il est essentiel de faire la distinction entre le diagnostic et le traitement médical de la maladie elle-même et la prise en charge des facteurs et problématiques associés pouvant influencer l’état général et la qualité de vie du patient.

Dans notre domaine, nous ne partons pas du principe que toute fatigue ou inflammation est causée par un « intestin perméable », et nous ne concluons pas non plus qu’un deuil ou un stress psychologique a causé une maladie auto-immune simplement parce qu’il a précédé l’apparition des symptômes.

Nous attendons qu’une investigation appropriée soit effectuée et qu’un diagnostic soit établi par le médecin spécialiste concerné.

La première question n’est donc pas :

« Quel était le facteur déclencheur ? »

Mais plutôt :

Quelle est la maladie ? Le diagnostic est-il établi ? Quel est son niveau d’activité ? Quels organes sont atteints ? Existe-t-il des signaux d’alarme ou des complications nécessitant une prise en charge médicale ou une orientation vers un spécialiste ?

Une fois cette base établie, les soins intégratifs de soutien peuvent intervenir parallèlement au suivi médical et au traitement prescrit lorsqu’il est indiqué.

C’est à ce stade que nous examinons la situation clinique dans son ensemble, notamment :

Santé gastro-intestinale

Sommeil et santé circadienne

Régulation du stress

Activité physique et récupération

Approche de soutien informée par les interactions neuro-immunitaires

Interactions médicaments–suppléments : le terme « naturel » ne signifie pas automatiquement « sans danger », particulièrement chez une personne prenant des corticostéroïdes, des immunosuppresseurs, des traitements biologiques ou des thérapies ciblées.

Comorbidités et risque cardiométabolique : notamment le poids, la pression artérielle, la régulation de la glycémie, les lipides et la santé osseuse, selon la maladie et les traitements utilisés.

Et ici se trouve un principe fondamental :

Soutien ≠ Remplacement

Améliorer le sommeil, la nutrition, la santé gastro-intestinale ou la gestion du stress peut apporter un soutien réel, mais cela ne signifie pas automatiquement que l’auto-immunité s’est arrêtée.

Si un patient a besoin d’un DMARD, d’un traitement immunosuppresseur, d’un médicament biologique ou d’une thérapie ciblée pour protéger ses articulations, sa peau, ses reins, ses poumons, son système nerveux, ses vaisseaux sanguins ou d’autres organes, ce traitement ne doit pas être remplacé par des suppléments, des interventions alimentaires ou une recherche incessante d’une « cause profonde ».

Cela ne signifie pas pour autant que les soins de soutien sont sans importance.

Nous pouvons plutôt considérer qu’il existe deux voies complémentaires :

Diagnostic médical et contrôle de la maladie
→ Établir le diagnostic
→ Évaluer l’activité de la maladie et l’atteinte des organes
→ Contrôler l’inflammation et l’activité immunitaire anormales
→ Prévenir les lésions organiques et les complications

Soins intégratifs de soutien
→ Évaluer les facteurs associés et modifiables
→ Prendre en compte les déficiences documentées
→ Prendre en charge les symptômes gastro-intestinaux lorsqu’ils sont présents
→ Soutenir le sommeil
→ Soutenir la régulation du stress
→ Encourager une activité physique adaptée
→ Soutenir la santé métabolique
→ Vérifier la sécurité des suppléments et les interactions potentielles
→ Soutenir la qualité de vie et l’adhésion au plan de traitement médical

L’objectif n’est pas de dire :

« Nous avons trouvé le facteur déclencheur; nous avons donc traité la maladie auto-immune. »

Mais plutôt :

Nous cherchons d’abord à comprendre la maladie, nous respectons le diagnostic, sa physiopathologie et le traitement médical nécessaire, puis nous identifions de manière méthodique les facteurs associés et modifiables que nous pouvons soutenir dans les limites de notre champ de pratique.

Pour moi, c’est cela, les soins intégratifs cliniques :

Investigation → Diagnostic → Identification des signaux d’alarme → Compréhension de la physiopathologie → Respect du traitement médical → Puis intégration d’un soutien individualisé.

La véritable médecine intégrative ne concurrence pas le diagnostic médical — elle s’appuie sur celui-ci.

Not everything that research shows can change a number on a lab test means that it has been proven to protect people from disease.

In scientific research, we should always ask:

Research proved WHAT exactly?

Did the study show that a drug acts on a specific mechanism?
Did it show improvement in a biomarker / surrogate outcome, such as LDL-C, ApoB, or triglycerides?
Or did it actually demonstrate better clinical outcomes, such as fewer heart attacks, strokes, or cardiovascular deaths?

For example, studies may clearly show that a drug lowers LDL-C, but that alone does not automatically mean that the drug has been proven to reduce cardiovascular events. To demonstrate that, we need cardiovascular outcome trials that directly assess those events.

The key message:

“Research proved it” is not the end of the discussion.
The more important scientific question is: What exactly did the research prove?

Improving a number ≠ automatically improving a clinical outcome.

NAVIER-STOKES & MEDICAL FUTURE :

Valve replacement → anatomy/CT sizing + pressure/velocity/flow + Computational Fluid Dynamics (CFD) → assess hemodynamic performance & optimize procedural planning.

Aneurysm → geometry + Navier–Stokes + Computational Fluid Dynamics (CFD) → understand flow forces → potentially improve risk assessment & device planning.

The Risks of Social Media in Healthcare Decisions: When Watching Becomes a “Medical Degree”

Today, anyone can open a social media account, publish a video, and present medical information with remarkable confidence.

The problem is not that parents or patients search for information. They should ask questions. They should understand what is being recommended to them. They should participate in informed decision-making.

The problem begins when repeated exposure to social-media content is mistaken for medical education, and an algorithm becomes a substitute for physiology, pathophysiology, epidemiology, clinical reasoning, and evidence appraisal.

Watching dozens of reels about vaccines does not provide the equivalent of studying Immunology, Epidemiology, Pharmacovigilance, Risk–Benefit Analysis, or critically evaluating the original scientific literature.

A good example is the frequently repeated story that:

“Japan banned MMR because of its dangers and its association with autism.”

What Actually Happened in Japan?

Japan introduced the combined MMR vaccine — Measles, Mumps and Rubella — in 1989 and discontinued its domestic MMR program in 1993 after detecting an unacceptably high rate of aseptic meningitis following vaccination.

That safety signal was real.

It was identified.
It was investigated.
And vaccination policy was changed.

But an essential part of the story is frequently omitted on social media.

The safety concern was primarily associated with the mumps component and mumps vaccine strains used in Japan at the time, including Urabe Am9 and domestically produced strains.

This was not a situation in which an old “live virus vaccine” was later changed into a “half-live vaccine.”

MMR vaccines are live attenuated vaccines. The relevant historical issue involved the safety characteristics of particular vaccine strains, not a change from “live” to “half-live.”

Different mumps vaccine strains do not necessarily have identical safety profiles. Published evidence, for example, has associated the Jeryl Lynn strain with a substantially lower risk of vaccine-associated aseptic meningitis than the Urabe strain.

This is actually an important example of pharmacovigilance working as intended:

Intervention → Safety Signal → Investigation → Causal Assessment → Modification of Practice

Did Japan Discover That MMR Causes Autism?

No.

Japan's historical decision was driven primarily by the problem of aseptic meningitis associated with the mumps component, not by evidence that MMR caused autism.

The MMR–autism controversy became internationally prominent following a report published in 1998 that was subsequently retracted. Large epidemiological studies conducted afterward have not established a causal relationship between MMR vaccination and autism.

Therefore:

Japan + MMR + 1993 ≠ MMR causes autism

A historical safety event cannot simply be removed from its scientific context and transformed into evidence for an unrelated causal claim.

---

And What About Vitamin K for Newborns?

Another concerning consequence of social-media misinformation is that some parents have become afraid of the Vitamin K injection given at birth, sometimes placing it in the same category as vaccines.

But:

Vitamin K injection is not a vaccine.

It is vitamin prophylaxis used to prevent Vitamin K Deficiency Bleeding (VKDB).

Newborns naturally begin life with relatively low Vitamin K stores. Placental transfer is limited, the newborn intestinal microbiome has not yet developed sufficiently to contribute substantially to Vitamin K availability, and breast milk contains relatively small amounts.

Vitamin K is essential for the normal activation of several coagulation factors.

Severe deficiency can therefore result in potentially catastrophic bleeding, including:

Intracranial hemorrhage — bleeding inside the skull or brain.

A newborn can appear completely healthy before serious late VKDB occurs.

According to CDC data, infants who do not receive the Vitamin K injection at birth have an approximately 81-fold greater risk of late VKDB than infants who receive it, and a substantial proportion of late VKDB cases involve intracranial bleeding.

Rejecting Vitamin K because of generalized fear surrounding “vaccines” therefore reflects a fundamental misunderstanding:

Vitamin K is not a vaccine, and the physiological reason for administering it is entirely different.

---

Social Media Should Generate Questions — Not Diagnoses

The appropriate response to medical misinformation is not blind trust in medicine either.

Patients have every right to ask:

Why do I need this?
What is the evidence?
What are the known risks?
What happens if I decline it?
Is this an association or established causation?
Does an adverse-event report prove that the intervention caused the event?
Is today's product or vaccine strain the same one involved in a historical safety problem?

Those are legitimate questions.

I welcome patients who ask questions, want to understand the evidence, and participate thoughtfully in decisions concerning their health.

What I cannot work with is a situation in which social-media content has already been treated as a medical doctorate, the conclusion has already been made, and the healthcare professional is expected simply to validate it.

There is a fundamental difference between being an informed patient and replacing professional clinical reasoning with an algorithmic feed.

A reel can introduce a question.
A post can encourage someone to investigate.
A personal testimony can identify an experience worth examining.

But none of them, by themselves, establish causation or replace clinical evidence.

The responsible approach to healthcare is neither fear nor blind reassurance.

It is:

Physiology → Pathophysiology → Risk → Evidence → Causation → Benefit vs. Harm → Individual Clinical Context

Social Media can open the door to a medical question. It should never be mistaken for the medical degree required to answer it.



---

مخاطر وسائل التواصل الاجتماعي على القرارات الصحية: عندما تتحول المشاهدة إلى «دكتوراه في الطب»

اليوم، يستطيع أي شخص أن يفتح حسابًا على وسائل التواصل الاجتماعي، وينشر فيديو، ويقدّم معلومة طبية بثقة كبيرة.

المشكلة ليست في أن الأهل أو المرضى يبحثون عن المعلومات. من حقهم أن يسألوا، ومن حقهم أن يفهموا ما يُقترح عليهم، ومن حقهم أن يشاركوا في اتخاذ القرار الصحي.

المشكلة تبدأ عندما تتحول مشاهدة عشرات الفيديوهات والمنشورات إلى بديل عن Physiology, Pathophysiology, Epidemiology, Clinical Reasoning وقراءة وتقييم الـscientific evidence.

مشاهدة عشرات الـReels عن اللقاحات لا تعادل دراسة Immunology, Epidemiology, Pharmacovigilance, Risk–Benefit Analysis، ولا تعادل القدرة على تقييم الدراسات العلمية الأصلية ونوعيتها.

ومن أفضل الأمثلة على ذلك القصة المتداولة:

«اليابان منعت MMR بسبب مخاطره وعلاقته بالتوحّد.»

ماذا حدث فعلًا في اليابان؟

أدخلت اليابان اللقاح الثلاثي MMR — Measles, Mumps, Rubella عام 1989، ثم أوقفت برنامج الـMMR المحلي عام 1993 بعد رصد معدل مرتفع بصورة غير مقبولة من:

Aseptic meningitis — التهاب السحايا العقيم

إذن، كانت هناك بالفعل safety signal حقيقية.

تم رصدها.
تم التحقيق فيها.
وتم تغيير سياسة التلقيح.

وهذا أمر مهم جدًا، لأنه يوضح أن أنظمة مراقبة سلامة اللقاحات موجودة تحديدًا لاكتشاف مثل هذه المشكلات.

لكن هناك جزءًا أساسيًا من القصة لا تخبرنا به بعض منشورات الـSocial Media.

المشكلة ارتبطت بصورة أساسية بـmumps component — مكوّن لقاح النكاف وبـmumps vaccine strains كانت مستخدمة في اليابان آنذاك، ومنها Urabe Am9 وبعض السلالات المنتجة محليًا في اليابان.

وهذا لا يعني أن اللقاح القديم كان يحتوي على «فيروس حي»، ثم أصبح اللقاح الحديث يحتوي على فيروس «نصف حي».

هذه ليست الطريقة العلمية لوصف ما حدث.

لقاحات MMR هي live attenuated vaccines — لقاحات حيّة مُضعَّفة.

المشكلة التاريخية كانت مرتبطة بخصائص وسلامة بعض vaccine strains المستخدمة، وليس بتحويل اللقاح من «حي» إلى «نصف حي».

كما أن الـvaccine strains ليست جميعها متطابقة من ناحية الـsafety profile. وقد ارتبطت سلالات أخرى، مثل Jeryl Lynn mumps strain، بخطر أقل بكثير من الـaseptic meningitis مقارنةً بـUrabe في البيانات المنشورة.

وهذه القصة، بدل أن تكون دليلًا على فشل العلم، هي مثال مهم على عمل Pharmacovigilance:

Intervention → Safety Signal → Investigation → Causal Assessment → Modification of Practice

هل اكتشفت اليابان أن MMR يسبب التوحّد؟

لا.

القرار الياباني التاريخي كان مدفوعًا أساسًا بمشكلة aseptic meningitis المرتبطة بمكوّن النكاف، وليس بدليل على أن MMR يسبب Autism.

أما الجدل العالمي حول MMR والتوحّد، فقد اشتهر خصوصًا بعد تقرير نُشر عام 1998 ثم سُحب لاحقًا. والدراسات الوبائية الكبيرة التي أُجريت لاحقًا لم تثبت وجود علاقة سببية بين لقاح MMR والتوحّد.

لذلك لا يمكن علميًا أن نكتب:

Japan + MMR + 1993 ≠ MMR causes Autism

لا يمكن أخذ مشكلة سلامة تاريخية حقيقية، وإخراجها من سياقها العلمي، ثم تحويلها إلى دليل على علاقة سببية مختلفة لم تثبتها البيانات.

---

وماذا عن Vitamin K الذي يُعطى للمولود؟

هنا نصل إلى نتيجة أخرى مقلقة للمعلومات الطبية المنتشرة على Social Media.

بعض الأهل أصبحوا يخافون من Vitamin K injection التي تُعطى بعد الولادة، وأحيانًا يتم وضعها في المجموعة نفسها مع اللقاحات.

لكن:

Vitamin K injection ليست Vaccine أصلًا.

إنها Vitamin prophylaxis هدفها الوقاية من:

Vitamin K Deficiency Bleeding — VKDB

المولود يأتي إلى الحياة طبيعيًا بمخزون منخفض نسبيًا من Vitamin K. انتقال Vitamin K عبر المشيمة محدود، والـintestinal microbiome عند المولود لم يتطور بعد بما يكفي ليساهم بصورة كبيرة في توفر Vitamin K، كما أن حليب الأم يحتوي كميات منخفضة نسبيًا منه.

وVitamin K ضروري للتفعيل الطبيعي لعدد من coagulation factors — عوامل التخثر.

لذلك فإن النقص الشديد قد يؤدي إلى نزيف خطير، ومن أخطر أشكاله:

Intracranial hemorrhage — نزيف داخل القحف/الدماغ

والأهم أن الطفل قد يبدو طبيعيًا تمامًا قبل حدوث late VKDB.

وبحسب بيانات CDC، الأطفال الذين لا يحصلون على Vitamin K injection عند الولادة لديهم خطر أعلى بنحو 81 مرة للإصابة بـlate VKDB مقارنةً بالأطفال الذين يحصلون عليها، ونسبة مهمة من حالات late VKDB تتضمن نزيفًا داخل القحف.

لذلك فإن رفض Vitamin K بسبب خوف عام من «اللقاحات» يقوم على خلط بين تدخلين مختلفين تمامًا:

Vitamin K ليست لقاحًا، والـphysiological rationale لإعطائها مختلف تمامًا.

---

Social Media يجب أن يصنع سؤالًا، لا أن يصنع تشخيصًا

الحل للمعلومات الطبية المضللة ليس أن نطلب من المريض الثقة العمياء بالطب.

من حق المريض أن يسأل:

لماذا أحتاج هذا التدخل؟
ما الدليل على فائدته؟
ما مخاطره المعروفة؟
ماذا يحدث إذا رفضته؟
هل ما نراه مجرد association أم ثبت causation؟
هل تسجيل adverse event يعني تلقائيًا أن التدخل سبّبه؟
هل المنتج أو الـvaccine strain المستخدمة اليوم هي نفسها التي ارتبطت بمشكلة تاريخية؟

هذه أسئلة مشروعة، بل مهمة.

وأنا أرحب بالمريض الذي يسأل، يناقش، يريد فهم الـevidence، ويشارك بوعي في القرارات المتعلقة بصحته.

لكن لا يمكن بناء علاقة صحية مهنية عندما تتحول مشاهدات الـSocial Media إلى «دكتوراه في الطب»، ويأتي المريض وقد أصدر مسبقًا التشخيص والحكم والنتيجة، ثم ينتظر من المختص فقط أن يؤكد له ما قرره الـalgorithm.

هناك فرق كبير بين:

Informed Patient — مريض مطّلع

وبين استبدال الـprofessional clinical reasoning بمحتوى الـSocial Media.

الـReel قد يفتح أمامك سؤالًا.
الـPost قد يدفعك إلى البحث.
والتجربة الشخصية قد تلفت الانتباه إلى شيء يستحق الدراسة.

لكن أيًا منها، بمفرده، لا يثبت causation ولا يحل محل clinical evidence.

القرار الصحي المسؤول لا يُبنى على التخويف، ولا على الطمأنة العمياء.

بل يُبنى على:

Physiology → Pathophysiology → Risk → Evidence → Causation → Benefit vs. Harm → Individual Clinical Context

وسائل التواصل الاجتماعي تستطيع أن تفتح باب السؤال الطبي، لكنها لا تمنح «دكتوراه في الطب» للإجابة عنه.

.com

NACR™ | Science Before Assumptions

NACR™ is an individualized, educational and complementary well-being approach centered on sensory awareness, self-regulation and neurophysiological understanding.

In complex contexts—including autonomic, neurodevelopmental, cognitive and emotional patterns—one principle remains fundamental:

> “We never confuse anatomical plausibility with demonstrated clinical efficacy.”

Understanding a neural pathway is only the beginning.

Does the pathway exist? → Anatomy & Physiology
Can a specific sensory input influence it? → Mechanistic Hypothesis
Has that influence been shown to produce meaningful and reproducible outcomes? → Clinical Evidence

NACR™ emphasizes individualized observation, evidence-informed neurophysiological reasoning, measurable responses, reassessment, and respect for the limits of current evidence—without assuming that a plausible mechanism is a proven clinical effect.

Neuroscience should never be used simply to make an intervention sound scientific.

It should help us ask better questions, distinguish hypotheses from established evidence, observe responses carefully, and remain within the boundaries of what science can currently support.

Complementary means working hand in hand—not replacing medical care.

When symptoms or a medical, neurological, developmental, or mental-health condition are present or suspected, appropriate assessment, diagnosis, treatment and follow-up remain within the care of qualified healthcare professionals.

NACR™ may accompany that care as a complementary educational and well-being approach. It does not provide medical diagnosis or replace medical or psychological treatment, prescribed medication, emergency care, or appropriate professional follow-up.

Classical medicine and complementary support can work hand in hand—each within its appropriate scope.

Why Personalized NACR™?

Every person presents a different story, pattern and context. That is why NACR™ is personalized rather than based on a one-size-fits-all protocol.

If you are looking for an individualized complementary approach that respects neuroscience, scientific evidence and the boundaries of medical care, you may reserve a NACR™ consultation.

Paid consultations • By appointment
Reservation: [email protected]






.com